small molecule

FENSOLVI KIT

LEUPROLIDE ACETATE

Loss of exclusivityDecember 2041latest FDA-listed patent expiry

CompanyTOLMAR INTERNATIONAL LTD

Drug detail

Brand name	FENSOLVI KIT
Active ingredient	LEUPROLIDE ACETATE
Strength	45MG
Dosage form	POWDER
Route	SUBCUTANEOUS
Modality	Small molecule
FDA approval	May 2020
Marketing status	RX

Listed patents

Patent	Expires	Type
12397120	December 2041	use U-3611
11931559	December 2041	substance
11771841	December 2041	substance, product

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.